Silexion Therapeutics (SLXN) on Friday reported a mixed shelf offering, worth $100 million, by which it will sell its ordinary shares, warrants and units overtime.
Shares of the biotech company closed around 2% lower on Friday.
Silexion Therapeutics (SLXN) on Friday reported a mixed shelf offering, worth $100 million, by which it will sell its ordinary shares, warrants and units overtime.
Shares of the biotech company closed around 2% lower on Friday.
Comments